Roger R Dmochowski Selected Research

oxybutynin (Tavor)

4/2016	An update on the use of transdermal oxybutynin in the management of overactive bladder disorder.
6/2012	Oxybutynin gel for the treatment of overactive bladder.
1/2011	Pharmacokinetics of oxybutynin chloride topical gel: effects of application site, baths, sunscreen and person-to-person transference.
4/2009	Efficacy and safety of oxybutynin chloride topical gel for overactive bladder: a randomized, double-blind, placebo controlled, multicenter study.
1/2007	Safety and tolerability of extended-release oxybutynin once daily in urinary incontinence: combined results from two phase 4 controlled clinical trials.
12/2006	The impact of the overactive bladder syndrome on sexual function: a preliminary report from the Multicenter Assessment of Transdermal Therapy in Overactive Bladder with Oxybutynin trial.
11/2006	Transdermal oxybutynin for overactive bladder.
9/2006	Transdermal drug delivery treatment for overactive bladder.
1/2006	Management of overactive bladder with transdermal oxybutynin.
10/2005	Efficacy and safety of extended release oxybutynin for the treatment of urge incontinence: an analysis of data from 3 flexible dosing studies.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Roger R Dmochowski Research Topics

Disease

37	Overactive Urinary Bladder (Overactive Bladder) 01/2021 - 08/2002
18	Stress Urinary Incontinence 01/2019 - 08/2002
15	Urinary Incontinence 01/2021 - 08/2002
9	Urge Urinary Incontinence (Urge Incontinence) 01/2021 - 06/2003
7	Nocturia 01/2021 - 11/2012
5	Urinary Retention 01/2022 - 05/2011
5	Wounds and Injuries (Trauma) 08/2018 - 10/2015
4	Constipation 04/2016 - 09/2005
4	Pelvic Organ Prolapse 05/2014 - 05/2012
3	Infections 01/2022 - 04/2008
3	Spinal Cord Injuries (Spinal Cord Injury) 01/2020 - 06/2002
3	Polyuria 01/2019 - 12/2017
3	Rupture 03/2018 - 03/2016
3	Fistula 09/2014 - 01/2007
3	Prolapse 01/2007 - 06/2002
3	Pruritus (Itching) 09/2005 - 08/2002
2	Dementia (Dementias) 01/2022 - 01/2021
2	Obesity 01/2021 - 06/2017
2	Hypertension (High Blood Pressure) 01/2021 - 01/2019
2	Multiple Sclerosis 01/2020 - 04/2013
2	Urethral Obstruction 08/2018 - 06/2002
2	Weight Loss (Weight Reduction) 06/2017 - 10/2011
2	Pelvic Pain 01/2015 - 01/2005
2	Hemorrhage 11/2014 - 06/2002
2	Neurogenic Urinary Bladder (Bladder, Neurogenic) 05/2014 - 03/2011
2	Pain (Aches) 05/2012 - 08/2008
2	Lower Urinary Tract Symptoms 07/2011 - 10/2009
2	Wound Infection (Wound Infections) 05/2011 - 06/2002
2	Inflammation (Inflammations) 06/2008 - 01/2008
2	Vesicovaginal Fistula 01/2007 - 01/2007
1	Edema (Dropsy) 01/2021
1	Diabetes Mellitus 01/2021
1	Heart Failure 01/2021
1	Chronic Renal Insufficiency 01/2021
1	Cognitive Dysfunction 01/2021
1	Vascular Remodeling 10/2020
1	Multiple Abnormalities 10/2020
1	Stroke (Strokes) 01/2020
1	Cystitis 10/2018
1	Bacteriuria 10/2018
1	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 01/2018
1	Anxiety Disorders (Anxiety Disorder) 01/2018
1	Hyponatremia 12/2017
1	Spinal Dysraphism (Spina Bifida) 10/2017
1	Substance-Related Disorders (Drug Abuse) 06/2017
1	Uterine Prolapse (Vaginal Prolapse) 01/2017
1	Vaginal Fistula 01/2017

Drug/Important Bio-Agent (IBA)

16	oxybutynin (Tavor)FDA LinkGeneric 04/2016 - 08/2002
12	Muscarinic AntagonistsIBA 01/2021 - 12/2003
8	Pharmaceutical PreparationsIBA 01/2018 - 12/2002
6	Cholinergic Antagonists (Anticholinergics)IBA 01/2022 - 09/2005
6	Type A Botulinum Toxins (Botox)FDA Link 01/2021 - 11/2009
6	SuspensionsIBA 06/2017 - 10/2002
5	Deamino Arginine Vasopressin (Desmopressin)FDA LinkGeneric 01/2019 - 11/2012
4	DiureticsIBA 01/2021 - 12/2017
4	fesoterodine FDA Link 12/2013 - 01/2010
4	trospium chloride (Ceris)FDA LinkGeneric 09/2011 - 03/2008
3	Nasal SpraysIBA 01/2019 - 12/2017
3	Polypropylenes (Polypropylene)IBA 05/2014 - 08/2008
3	tyramine-deoxysorbitolIBA 09/2005 - 08/2002
3	Tolterodine Tartrate (Detrol)FDA Link 06/2005 - 06/2003
2	Anti-Bacterial Agents (Antibiotics)IBA 12/2020 - 10/2018
2	CollagenIBA 10/2020 - 08/2002
2	TabletsIBA 01/2019 - 09/2013
2	Interleukin-6 (Interleukin 6)IBA 06/2008 - 01/2008
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 06/2008 - 01/2008
2	Delayed-Action PreparationsIBA 06/2005 - 06/2003
2	Muscarinic Receptors (Muscarinic Acetylcholine Receptor)IBA 12/2003 - 10/2002
1	Botulinum Toxins (Botulinum Toxin)IBA 01/2021
1	litoxetineIBA 01/2021
1	ORALIT (ORS)IBA 01/2021
1	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 01/2021
1	purineIBA 10/2020
1	Vasopressins (Vasopressin)IBA 01/2019
1	4-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA 01/2018
1	Indicators and Reagents (Reagents)IBA 01/2018
1	ElectrolytesIBA 06/2017

Therapy/Procedure

21	Therapeutics 01/2019 - 08/2002
8	Suburethral Slings (Tension-Free Vaginal Tape) 06/2017 - 10/2004
4	Denervation 11/2019 - 01/2019
4	Conservative Treatment 11/2017 - 06/2002
4	Drug Therapy (Chemotherapy) 06/2017 - 12/2003
4	Operative Surgical Procedures 08/2008 - 07/2003
3	Catheters 01/2022 - 03/2016
3	Cystectomy 01/2020 - 05/2012
3	Aftercare (After-Treatment) 03/2018 - 12/2006
2	Prostheses and Implants (Prosthesis) 01/2022 - 06/2002
2	Artificial Urinary Sphincter 12/2020 - 09/2003
2	Injections 01/2019 - 08/2002
2	Off-Label Use 01/2018 - 12/2017
2	Urinary Diversion (Ileal Conduit) 05/2017 - 09/2014
2	Length of Stay 04/2017 - 11/2015
2	Blood Transfusion (Blood Transfusions) 11/2014 - 06/2014
2	Surgical Instruments (Clip) 11/2014 - 05/2012
2	Prostatectomy (Retropubic Prostatectomy) 08/2007 - 06/2002
1	Cystoscopes 08/2018
1	Cystostomy (Suprapubic Cystostomy) 08/2018
1	Contraindications 12/2017
1	Urinary Catheters 11/2017
1	Laparotomy 10/2017